TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3
about
Extended-spectrum beta-lactamases: a clinical updateTEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).A marine-derived Streptomyces sp. MS449 produces high yield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity.CMT-type beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-lactamase detection.Virulence factors and TEM-type β-lactamases produced by two isolates of an epidemic Klebsiella pneumoniae strain.Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance.In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?Resistance to beta-lactamase inhibitor protein does not parallel resistance to clavulanic acid in TEM beta-lactamase mutants.Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclorTEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.Characterization of the Novel CMT Enzyme TEM-154Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9.
P2860
Q24534999-26F5A50C-28CF-401E-AE99-66816DCAA2C1Q34123641-0E27312B-7BBC-4E57-8072-63F485DA217EQ34250434-6A92D672-FB8B-4683-AED0-5A2E0E7C2EB4Q34721603-BFF3F716-837A-4053-A6F5-7F5D37D609ADQ35689234-8B27AC92-0FB7-4EC5-9866-E02F4C5AD800Q35758897-E8BA620F-A120-48A4-95AE-7F79EA239CA7Q37624693-BC4FD55D-9DA8-4508-8B2A-84F9E542F588Q37735903-549DEFDF-49B1-4BA8-BA24-4F508263959EQ38626867-C1FDDE9A-3767-456B-A741-BB60101BA043Q39657859-F37A1353-C441-4A06-97C8-EDA90D5AF322Q39792503-94FBAB19-D70A-4598-AB08-8BB0D0D474E5Q42059997-3AABC8EF-6F91-4F6B-A5AB-22237D72DE72Q42276254-A28B18F1-D919-444D-8A58-2F507E87A721Q42925117-4FC54FB6-CD94-4260-BB6D-46C47A2AFE03
P2860
TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
TEM-89 beta-lactamase produced ...... both TEM-59 (IRT-17) and TEM-3
@en
TEM-89 beta-lactamase produced ...... al isolate: new complex mutant
@nl
type
label
TEM-89 beta-lactamase produced ...... both TEM-59 (IRT-17) and TEM-3
@en
TEM-89 beta-lactamase produced ...... al isolate: new complex mutant
@nl
prefLabel
TEM-89 beta-lactamase produced ...... both TEM-59 (IRT-17) and TEM-3
@en
TEM-89 beta-lactamase produced ...... al isolate: new complex mutant
@nl
P2093
P2860
P1476
TEM-89 beta-lactamase produced ...... both TEM-59 (IRT-17) and TEM-3
@en
P2093
A Kazmierczak
A Pechinot
C Neuwirth
M Fouchereau-Peron
M Pruneaux
P2860
P304
P356
10.1128/AAC.45.12.3591-3594.2001
P407
P577
2001-12-01T00:00:00Z